Yet another great discussion with the Karma Koala podcast back on hometurf.
Lisa has worked in the Australian & Asia Pacific medical supply industry for over two decades and in medical cannabis for the past 5 + years.
She knows through on the ground experience how the private sector has to interact with the medical profession as well as both state and federal govt from the perspective of politics and administration.
I haven’t as yet spoken to anybody with as much experience and knowledge about dealing with Australia’s TGA (Theraputic Goods Adminsistration) who are the gatekeepers when it comes to ensuring medical cannabis products make it to market in Australia. They are, as you will learn, in one segment of this conversation a law unto themselves and can be, shall we say, tricky, at the best of times!
In “The Dynamics of the Australian Landscape Pt1”
We discuss
The Australian medical cannabis environment
The market’s quick growth and government struggling to keep up.
Why is there no adult use legislation in Australia?
Has government created too many prescription categories?
Barriers to medical cannabis education in australia
Driving and cannabis, the ongoing debates
The essential conservatism in the Australian medical community
The opaque and sometimes obstreperous TGA ( Therapeutic Goods Authority)
Lisa Varley
Career in Cannabis
Varley’s involvement in the cannabis industry includes:
- Managing Director at MiDispensary and The Entourage Effect since April 2023
- Former Managing Director Australia at Beacon Medical Australia from March 2022 to April 2023
- Sales Director at Kind Medical from July 2021 to January 2022
These roles demonstrate her deep engagement with the medicinal cannabis sector in Australia.
Expertise and Influence
Lisa Varley is recognized for her insights into the cannabis industry:
- She has been invited as a speaker at the Cannabis Business Asia-Pacific 2024 conference, indicating her status as a thought leader in the field
Vision for Medicinal Cannabis
As the CEO of The Entourage Effect and MiDispensary, Varley views medicinal cannabis as a promising new treatment option. She is working to advance the industry and improve patient access to cannabis-based therapies.
Background and Qualifications
Varley’s expertise in the cannabis sector is built upon a strong foundation in healthcare and pharmaceuticals:
- She holds an MBA from the Australian Institute of Business
- Her career includes leadership roles at companies such as Soho Flordis International, Mundipharma Australia, and Fresenius Kabi
Lisa writes on her linked in
Specialties:
• Driving business by translating the technical into commercial and delivering year on year double digit growth despite heavy competition and a dynamic environment in Asia. This is greatly enhanced by being proactive, innovative and first to market by challenging the status quo and being ideas and solutions focused.
• Very well established Distributor & KOL relationships across all Asia
• Extensive knowledge of the complex Regulatory environment in Asia
• Vast expertise and experience across Asia Pacific region in all aspects of business specifically delivering innovative sales and marketing solutions especially in consideration of the local regulatory environment but also importantly local culture.
• Leading projects to success on or under budget and always on time or early
• Extensive and reliable network of contacts in the Asia region in Nutraceuticals, Complementary Medicine, OTC and Pharmaceuticals
